November 1, 1981Diabetes
Diabetic Hypertriglyceridemia: Evidence for Three Clinical Syndromes
Population
Man and rat models with impaired glucose tolerance, non-insulin-dependent diabetes mellitus, and…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May distinguish hypertriglyceridemia mechanisms across glucose disorders; leaves open prospective validation before clinical adoption.
Key Points
- To delineate the distinct pathophysiological mechanisms causing hypertriglyceridemia across three major categories of abnormal carbohydrate metabolism.
- Synthesized physiological and metabolic findings from studies in humans and rat models.
- Assessed the interactions among plasma insulin, free fatty acid concentrations, hepatic VLDL-triglyceride secretion, and peripheral lipid clearance.
- Impaired glucose tolerance leads to insulin resistance and compensatory hyperinsulinemia, driving increased hepatic VLDL-triglyceride secretion.
- Non-insulin-dependent diabetes presents with elevated circulating free fatty acids that stimulate hepatic VLDL-triglyceride overproduction despite normal baseline insulin levels.
- Insulin-dependent diabetes results in hypertriglyceridemia primarily through a severe defect in the plasma clearance of VLDL-triglycerides rather than enhanced hepatic secretion.
Structured PICO
P
Population
Man and rat models with impaired glucose tolerance (IGT), non-insulin-dependent diabetes mellitus (NIDDM), and insulin-dependent diabetes mellitus (IDDM)
O
Outcome
Mechanisms of hypertriglyceridemia development
Provides a conceptual model explaining the different pathophysiological mechanisms of hypertriglyceridemia across three major categories of abnormal carbohydrate metabolism.
Cite This Study
Reaven et al. (1981) studied this question.